Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging biomarkers in anaplastic oligodendroglioma: implications for clinical investigation and patient management.

CNS oncology - 1 Jul 2013

Sahebjam Solmaz, McNamara Mairéad G, Mason Warren P

Abstract excerpt

Oligodendrogliomas are heterogeneous tumors with a variable response to treatment. This clinical variability underlines the urgent need for markers that can reliably aid diagnosis and guide clinical decision-making. Long-term follow-up data from the EORTC 26951 and RTOG 9402 clinical trials in newly diagnosed anaplastic oligodendroglioma have established chromosome 1p19q codeletion as a predictive marker of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosome Deletion
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Management

Share to DNA Modification Methylases

Share to Isocitrate Dehydrogenase

Share to Longitudinal Studies

Share to Oligodendroglioma

Source

Open in PubMed Open full text

Identifiers

PMID: 25054579
DOI: 10.2217/cns.13.26
PMCID: PMC6166534

Genes

CIC
MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging biomarkers in anaplastic oligodendroglioma: implications for clinical investigation and patient management.PMID 25054579Read ↗

A Hypermethylated Phenotype Is a Better Predictor of Survival than <i>MGMT</i> Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951Semantic proximity Read ↗

Clinical impact of molecular biomarkers in gliomas.Semantic proximity Read ↗

Molecular neuro-oncology in clinical practice: a new horizon.Semantic proximity Read ↗

Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.Semantic proximity Read ↗

Oligodendroglioma: pathology, molecular mechanisms and markersSemantic proximity Read ↗

Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomasSemantic proximity Read ↗

Incorporating Advances in Molecular Pathology Into Brain Tumor DiagnosticsSemantic proximity Read ↗

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.Semantic proximity Read ↗

Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.Semantic proximity Read ↗

Clinical impact of molecular profiling in rare brain tumors.Semantic proximity Read ↗

Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.Semantic proximity Read ↗

The Role of Molecular Diagnostics in the Management of Patients with Gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.